AML is all clinical and biological weapons , unlike immunohistochemistry and prognostic . It is also the task of the epidemiological criteria :
AML with a nearly 3 per 100,000 people per year in France for the majority of adult diseases ;
Incidence increases steadily with age ;
The median age was 65 years , which reflects the pace in the elderly, and the earth where they are treated and are usually used because of the toxicity of chemotherapy.
LAM origin is unknown. However, identified a number of risk factors of blood cancer .
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.